PHDS HEALTHCARE RESEARCH Co., Ltd.
The PHDS senior team was invited to attend the reception hosted by the British Ambassador to China.
Release time:
2015-11-26
Riding on the "super results" brought by President Xi Jinping's "super visit" to the UK in November 2015, China-UK relations have entered a globally significant "golden era."
Riding on the "super results" brought by President Xi Jinping's "super visit" to the UK in November 2015, China-UK relations have entered a globally focused "golden era." The reception for the "Northern Ireland Multi-Industry Business Delegation" hosted by UK Ambassador to China Ms. Barbara Woodward and the Department for International Trade was held at the UK Embassy residence on November 24, 2015, with nearly 200 participants. The reception was a great success!
At the invitation of UK Ambassador to China Ms. Barbara Woodward, PHDS sent a senior team to attend the reception, where they had friendly conversations and took photos with Minister of State for Trade and Investment Mr. Jonathan Bell, as well as engaged in warm and sincere exchanges with CEOs or heads of health industry companies present. All parties expressed a positive intention for cooperation and shared relevant information, and follow-up work is gradually being advanced and negotiated.
We believe that this exchange activity will bring fruitful win-win results for Chinese and British enterprises.
Becoming a bridge for communication between the Eastern and Western health industries has always been PHDS's corporate historical mission, and we will certainly live up to this mission.
Keyword:
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22

京公网安备11010502056452号